First you need to realize that there are more than 70 different cannabinoids that have been identified so far and over 500 constituents of cannabis including various terpenoids and flavonoids. In fact, the US government holds multiple patents on various cannabinoids. They also hold patents defining these cannabinoids many medical benefits. One of these cannabinoids which has shown a huge amount of potential is CBD or Cannabidiol and while its potential could not possibly be understated there is another cannabinoid making headlines as well. Tetrahydrocannabidiol otherwise known as THC.
While there is much debate on which form is better, this 2015 study leans in favor of full spectrum CBD oil products. There are many that believe that other cannabinoids, THC especially, are necessary to take full advantage of what cannabis has to offer. Ultimately, however, we are all different and it comes down to the individual user and their needs. If drug testing is a concern, you’re encouraged to seek out CBD isolate products (or terpsolates) or broad spectrum products instead of full spectrum.
CBD vaporizer oils can be used in a vaporizer of your choice. They offer a healthy way of inhaling your daily dose of the CBD supplement. Vaping is a very direct way of ingesting CBD oil. When you vape, the CBD enters the lungs and goes directly into the bloodstream, completely bypassing the digestive system. This method allows for greater bioavailability.
When looking at isolate, it is important to verify the purity. While many are in the 99.9+% range with no identifiable amounts of THC, there are lower purity ones (such as 99.5% or lower) that may still have trace amounts that show up on the labs. This small amount is typically negligible, and is nowhere near the amount usually found in full spectrum products. But it’s still something to be aware of for those seeking the purest they can find.
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160